These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 25833690

  • 1. Gemcitabine impacts differentially on bladder and kidney cancer cells: distinct modulations in the expression patterns of apoptosis-related microRNAs and BCL2 family genes.
    Papadopoulos EI, Yousef GM, Scorilas A.
    Tumour Biol; 2015 May; 36(5):3197-207. PubMed ID: 25833690
    [Abstract] [Full Text] [Related]

  • 2. Cytotoxic activity of sunitinib and everolimus in Caki-1 renal cancer cells is accompanied by modulations in the expression of apoptosis-related microRNA clusters and BCL2 family genes.
    Papadopoulos EI, Yousef GM, Scorilas A.
    Biomed Pharmacother; 2015 Mar; 70():33-40. PubMed ID: 25776476
    [Abstract] [Full Text] [Related]

  • 3. miR-129-5p inhibits gemcitabine resistance and promotes cell apoptosis of bladder cancer cells by targeting Wnt5a.
    Cao J, Wang Q, Wu G, Li S, Wang Q.
    Int Urol Nephrol; 2018 Oct; 50(10):1811-1819. PubMed ID: 30117016
    [Abstract] [Full Text] [Related]

  • 4. Gemcitabine-induced apoptosis in 5637 cell line: an in-vitro model for high-risk superficial bladder cancer.
    Gazzaniga P, Silvestri I, Gradilone A, Scarpa S, Morrone S, Gandini O, Gianni W, Frati L, Aglianò AM.
    Anticancer Drugs; 2007 Feb; 18(2):179-85. PubMed ID: 17159604
    [Abstract] [Full Text] [Related]

  • 5. Long noncoding RNA FOXD2-AS1 accelerates the gemcitabine-resistance of bladder cancer by sponging miR-143.
    An Q, Zhou L, Xu N.
    Biomed Pharmacother; 2018 Jul; 103():415-420. PubMed ID: 29674277
    [Abstract] [Full Text] [Related]

  • 6. Comprehensive analysis of microRNA-messenger RNA regulatory network in gemcitabine-resistant bladder cancer cells.
    Zhang S, Chang YY, Gong YW, Gao YJ, Guo Q, Wang YH, Zhao YL, Wang ZP.
    J Cell Biochem; 2019 Apr; 120(4):6347-6360. PubMed ID: 30304549
    [Abstract] [Full Text] [Related]

  • 7. Array analysis for potential biomarker of gemcitabine identification in non-small cell lung cancer cell lines.
    Zhang HH, Zhang ZY, Che CL, Mei YF, Shi YZ.
    Int J Clin Exp Pathol; 2013 Apr; 6(9):1734-46. PubMed ID: 24040438
    [Abstract] [Full Text] [Related]

  • 8. Replication-competent adenovirus expressing TRAIL synergistically potentiates the antitumor effect of gemcitabine in bladder cancer cells.
    Mao L, Yang C, Li L, Nai L, Fan L, Wang J, Li W, Wen R, Chen J, Zheng J.
    Tumour Biol; 2014 Jun; 35(6):5937-44. PubMed ID: 24604329
    [Abstract] [Full Text] [Related]

  • 9. Licochalcone C induces apoptosis via B-cell lymphoma 2 family proteins in T24 cells.
    Wang P, Yuan X, Wang Y, Zhao H, Sun X, Zheng Q.
    Mol Med Rep; 2015 Nov; 12(5):7623-8. PubMed ID: 26397392
    [Abstract] [Full Text] [Related]

  • 10. Everolimus enhances gemcitabine-induced cytotoxicity in bladder-cancer cell lines.
    Pinto-Leite R, Arantes-Rodrigues R, Palmeira C, Gaivão I, Cardoso ML, Colaço A, Santos L, Oliveira P.
    J Toxicol Environ Health A; 2012 Nov; 75(13-15):788-99. PubMed ID: 22788366
    [Abstract] [Full Text] [Related]

  • 11. Induction of caspase mediated apoptosis and down-regulation of nuclear factor-κB and Akt signaling are involved in the synergistic antitumor effect of gemcitabine and the histone deacetylase inhibitor trichostatin A in human bladder cancer cells.
    Jeon HG, Yoon CY, Yu JH, Park MJ, Lee JE, Jeong SJ, Hong SK, Byun SS, Lee SE.
    J Urol; 2011 Nov; 186(5):2084-93. PubMed ID: 21944112
    [Abstract] [Full Text] [Related]

  • 12. BMI1 activates P-glycoprotein via transcription repression of miR-3682-3p and enhances chemoresistance of bladder cancer cell.
    Chen MK, Zhou JH, Wang P, Ye YL, Liu Y, Zhou JW, Chen ZJ, Yang JK, Liao DY, Liang ZJ, Xie X, Zhou QZ, Xue KY, Guo WB, Xia M, Bao JM, Yang C, Duan HF, Wang HY, Huang ZP, Qin ZK, Liu CD.
    Aging (Albany NY); 2021 Jul 16; 13(14):18310-18330. PubMed ID: 34270461
    [Abstract] [Full Text] [Related]

  • 13. Toxicogenomic activity of gemcitabine in two TP53-mutated bladder cancer cell lines: special focus on cell cycle-related genes.
    da Silva GN, de Camargo EA, Salvadori DM.
    Mol Biol Rep; 2012 Dec 16; 39(12):10373-82. PubMed ID: 23053941
    [Abstract] [Full Text] [Related]

  • 14. Lentinan reduces tumor progression by enhancing gemcitabine chemotherapy in urothelial bladder cancer.
    Sun M, Zhao W, Xie Q, Zhan Y, Wu B.
    Surg Oncol; 2015 Mar 16; 24(1):28-34. PubMed ID: 25434982
    [Abstract] [Full Text] [Related]

  • 15. Garcinol sensitizes human pancreatic adenocarcinoma cells to gemcitabine in association with microRNA signatures.
    Parasramka MA, Ali S, Banerjee S, Deryavoush T, Sarkar FH, Gupta S.
    Mol Nutr Food Res; 2013 Feb 16; 57(2):235-48. PubMed ID: 23293055
    [Abstract] [Full Text] [Related]

  • 16. Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine.
    Isono M, Hoffmann MJ, Pinkerneil M, Sato A, Michaelis M, Cinatl J, Niegisch G, Schulz WA.
    J Exp Clin Cancer Res; 2017 Jan 03; 36(1):1. PubMed ID: 28049532
    [Abstract] [Full Text] [Related]

  • 17. Deoxycytidine kinase expression underpins response to gemcitabine in bladder cancer.
    Kerr M, Scott HE, Groselj B, Stratford MR, Karaszi K, Sharma NL, Kiltie AE.
    Clin Cancer Res; 2014 Nov 01; 20(21):5435-45. PubMed ID: 25224279
    [Abstract] [Full Text] [Related]

  • 18. Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells.
    Pan J, Li X, Wu W, Xue M, Hou H, Zhai W, Chen W.
    Cancer Lett; 2016 Nov 01; 382(1):64-76. PubMed ID: 27591936
    [Abstract] [Full Text] [Related]

  • 19. -(-)Gossypol promotes the apoptosis of bladder cancer cells in vitro.
    Macoska JA, Adsule S, Tantivejkul K, Wang S, Pienta KJ, Lee CT.
    Pharmacol Res; 2008 Nov 01; 58(5-6):323-31. PubMed ID: 18840529
    [Abstract] [Full Text] [Related]

  • 20. 1,25D3 enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer models.
    Ma Y, Yu WD, Trump DL, Johnson CS.
    Cancer; 2010 Jul 01; 116(13):3294-303. PubMed ID: 20564622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.